| 000 | 00901 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517113019.0 | ||
| 264 | 0 | _c20180730 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1474-4457 | ||
| 024 | 7 |
_a10.1016/S1473-3099(16)30334-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aByass, Peter | |
| 245 | 0 | 0 |
_aTuberculosis: a private and public health and data mix. _h[electronic resource] |
| 260 |
_bThe Lancet. Infectious diseases _c11 2016 |
||
| 300 |
_a1206-1207 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntitubercular Agents |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPublic Health |
| 650 | 0 | 4 | _aPublic-Private Sector Partnerships |
| 650 | 0 | 4 | _aTuberculosis |
| 773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 16 _gno. 11 _gp. 1206-1207 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(16)30334-6 _zAvailable from publisher's website |
| 999 |
_c26366968 _d26366968 |
||